Remimazolam tosylate or propofol and delirium in frail elderly patients after hip surgery: A randomised controlled clinical trial

医学 异丙酚 谵妄 入射(几何) 麻醉 全身麻醉 不利影响 外科 内科学 重症监护医学 光学 物理
作者
Wenlan Cai,Fangming Shen,Lan-yue Zhu,Yuqing Xue,Menghan Sun,Xiaoxiang Tan,Kaikai Shi,Yuzhou Chen,Jie Sun
出处
期刊:European Journal of Anaesthesiology [Lippincott Williams & Wilkins]
卷期号:42 (12): 1064-1073 被引量:20
标识
DOI:10.1097/eja.0000000000002226
摘要

BACKGROUND: Remimazolam tosylate, a novel short-acting benzodiazepine, is increasingly being used in general anaesthesia, but its role in the incidence of postoperative delirium is uncertain, particularly in frail elderly patients. OBJECTIVE: To compare the effects of remimazolam tosylate with propofol on the incidence of postoperative delirium in frail elderly patients undergoing hip surgery. DESIGN: Randomised, single-centre, single-blind controlled trial. SETTING: A tertiary teaching hospital in China, conducted from March to December 2023. PATIENTS: Frail elderly patients (Reported Edmonton Frail Scale Score ≥ 6) undergoing hip surgery under general anaesthesia. INTERVENTIONS: Patients were randomly assigned to either the propofol or remimazolam group. Both groups received total intravenous anaesthesia following a standardised protocol with either propofol or remimazolam tosylate for induction and maintenance. MAIN OUTCOME MEASURES: The primary outcome was the incidence of postoperative delirium within three postoperative days, assessed twice daily using the 3D Confusion Assessment Method (3D-CAM). The secondary outcomes included the quality of postoperative recovery and adverse events. RESULT: A total of 136 patients were enrolled. The incidence of postoperative delirium was significantly lower in the remimazolam group than in the propofol group [3 of 68 (4.4%) vs. 12 of 68 (17.6%), risk differece (RD) -13.2%, 95% CI -23.5% to -2.9%, relative risk (RR) 0.25, 95% CI 0.074 to 0.847, NNT 7.6, P = 0.0143]. The incidence of hypotension after induction was also lower in the remimazolam group [16 of 68 (23.5%) vs. 32 of 68 (47.1%), RD -23.5%, 95%CI -39.1% to -8.0%, RR 0.5, 95% CI 0.304 to 0.822, NNT 4.3, P = 0.004], with fewer patients requiring vasopressors [55 of 68 (80.9%) vs. 66 of 68 (97.1%), RD -16.2%, 95% CI -26.3 to -6.0, RR 0.8, 95% CI 0.737 to 0.942, NNT 6.2, P = 0.003]. Notably, the remimazolam group exhibited significantly less burst suppression compared with the propofol group, both in terms of burst suppression time (2.2 s [0 to 17.6] vs. 21.9 s [2.3 to 115.3] median difference = 11.98 s, 95% CI 2.44 to 27.90, P < 0.001) and its proportion relative to the total surgery time (0.3‰ [0 to 2.1] vs. 2.8‰ [0.2 to 14.7], median difference 1.30‰, 95% CI 0.27 to 3.34, P < 0.001). CONCLUSION: In frail elderly patients, remimazolam tosylate was associated with a lower incidence of postoperative delirium compared with propofol. TRIAL REGISTRATION: Chinese Clinical Trial Registry, Chictr.org.cn, identifier: ChiCTR2300068632.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
酷酷班发布了新的文献求助10
1秒前
Porkpike完成签到,获得积分10
1秒前
2秒前
Ypearl发布了新的文献求助10
2秒前
2秒前
3秒前
xl完成签到,获得积分10
3秒前
3秒前
QLLW完成签到,获得积分10
4秒前
糖心发布了新的文献求助10
5秒前
哈哈发布了新的文献求助30
5秒前
一颗苹果发布了新的文献求助10
5秒前
5秒前
5秒前
NexusExplorer的应助被HJC采纳,获得10
5秒前
smile发布了新的文献求助10
5秒前
5秒前
Niko_Mak完成签到,获得积分10
6秒前
SHukie完成签到 ,获得积分10
6秒前
6秒前
6秒前
Ava的应助被俭朴钢铁侠采纳,获得10
7秒前
7秒前
祎辰完成签到 ,获得积分10
7秒前
7秒前
xh发布了新的文献求助20
7秒前
7秒前
Maestro_S的应助被科研通管家采纳,获得10
8秒前
YAMP完成签到,获得积分10
8秒前
李健的应助被科研通管家采纳,获得10
8秒前
8秒前
8秒前
cdercder的应助被科研通管家采纳,获得10
8秒前
浅梦发布了新的文献求助10
8秒前
英俊的铭的应助被科研通管家采纳,获得10
8秒前
Ava的应助被顺顺利利采纳,获得10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482